Slide 1: Strong sales and improved earnings – continued focus on customer value and profitability
Strong sales and improved earnings – continued focus on customer value and profitability going forward Getinge Q1 2025 Mattias Perjos, CEO Agneta Palmér, CFO
Slide 2: Key takeaways Q1 2025
Key takeaways Q1 2025 • Net sales grew by 10.7 % whereof 6.2% organically and order intake increased by 7.1% whereof 2.9% organically • Margins positively impacted by volume, acquisitions, price and mix • The financial position remains solid 35,566 36,000 55 15 14.1 34,000 14 50.3 32,000 50 0 0 Q1 2
Slide 3: Key activities and events
Key activities and events Q1 2025 Sustainability and Quality Offering and customers • Findings per regulatory audit is down • Paragonix continues its strong performance. Successful versus last year. introduction of KidneyVault and 5 out of 6 of products have received EU MDR approval. • Field correct
Slide 4: Strong top line performance in Acute Care Therapies in the quarter
Strong top line performance in Acute Care Therapies in the quarter Order Intake and Net Sales Bridge Q1 2024 – Q1 2025 Order Intake Net Sales Organic Organic change +8.6% -12.9% +0.3% +2.9% change +12.4% -2.3% -0,2% +6.2% +7.1% +10.7% 681 806 16 28 -14 -135 8,632 8,320 8,059 SEK M SEK M 7,513 Q1 202
Slide 5: Margins positively impacted by net sales growth and mix
Margins positively impacted by net sales growth and mix Adjusted Gross Profit and EBITA Bridge Q1 2024 – Q1 2025 Adjusted Gross Profit Adjusted EBITA Adj GM,% Margin development Q1 2025 60.6 39.4 41.2 52.1 +0.3 pp Adj GP (Q1 2024) (60.2) (40.5) (41.7) (51.3) +1.5 pp Adj OPEX +0.2 pp D&A -1.1 pp FX +
Slide 6: Leverage continues to move down
Leverage continues to move down Capital efficiency and financial position FCF impacted by inventory build up, reduced liabilities … and leverage continues to be way below 2.5x and restructuring payouts … 2.0 1.5 1.6 1.4 1.4 1.7 2.0 0.9 1.5 1.6 1.4 (1.1x excl. 0.4 0.3 pension liabilities) 0.2 Q1 2024
Slide 7: Key pillars for Getinge's profitable growth journey
Key pillars for Getinge’s profitable growth journey Development for strategic KPIs Increase share from recurring revenue Increase sales share from high margin products1 Less field actions per Bn SEK Net sales Capital goods Recurring revenue Rest of Portfolio High margin products 1,9 -37% 1,2 60% 65%
Slide 8: Navigating dynamic market characteristics and geopolitical uncertainty
Navigating dynamic market characteristics and geopolitical uncertainty Examples of major influences being monitored and addressed US: Research funding and Global: High tariffs Global: Budget priorities structural changes at regulatory authorities • Close dialogue with customers and authorities • Pri
Slide 9: Getinge has a geographically diversified production footprint
Getinge has a geographically diversified production footprint Main products produced per region USA European Union China Acute Care Therapies Acute Care Therapies Acute Care Therapies • Cardiovascular Surgery • Cardiopulmonary • Critical Care • Cardiac Assist • Critical Care • Cardiovascular Surgery
Slide 10: About 60% of US sales is produced domestically
About 60% of US sales is produced domestically Production origin as share of sales in USA, EU and China USA European Union China ~14 BSEK ~8 BSEK ~3 BSEK Net Sales 2024 Net Sales 2024 Produced in Net Sales 2024 Getinge │ Presentation │ Q1 Report 2025 April 22, 2025
Slide 11: Outlook 2025
Outlook 2025 Net sales for 2025 expected to increase by 2-5% organically Getinge │ Presentation │ Q1 Report 2025 April 22, 2025
Slide 12: Summary
Summary Getinge │ Presentation │ Q1 Report 2025 April 22, 2025
Slide 13: Key takeaways Summary Q1 2025
Key takeaways Summary Q1 2025 • Strong sales performance and improved margins in Q1 • Reduced leverage and solid financial position remains • Kept outlook for 2025: organic net sales growth of 2-5% Getinge │ Presentation │ Q1 Report 2025 April 22, 2025
Slide 14: Q&A
Q&A Getinge │ Presentation │ Q1 Report 2025 April 22, 2025
Slide 15: Thank you
Thank you Getinge │ Presentation │ Q1 Report 2025 April 22, 2025
Slide 16: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectation
Slide 17: Getinge – Passion for Life
“= Se A GETINGE PASSION FOR LIFE